Inventor · disambiguated record
Nicolas Luc Sabourault
Also filed as: REBIERE FRANCOIS · SABOURAULT NICOLAS · SABOURAULT NICOLAS LUC
8 granted patents·2 pending applications·33 citations·filing 2011–2025
86Inventor score
Top patents by PatentIndex Score
10 records- 0196US12234235B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersALFASIGMA SPA·Filed 2023·Granted Feb 25, 2025·2 cites·4 claims
- 0295US11667633B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2021·Granted Jun 6, 2023·4 cites·4 claims
- 0393US10708263B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2017·Granted Jul 7, 2020·5 cites·6 claims
- 0493US9382247B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Jul 5, 2016·12 cites·2 claims
- 0585US10919890B2Salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2019·Granted Feb 16, 2021·4 cites·4 claims
- 0676US2025289816A1Salts and pharmacutical compositions thereof for the treatment of inflammatory disordersALFASIGMA SPA·Filed 2025·Application pending·0 cites
- 0774US10493158B2Pharmaceutical compositions for the treatment of inflammatory disordersGALAPAGOS NV·Filed 2015·Granted Dec 3, 2019·4 cites·18 claims
- 0874US8318979B2Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidationCOURVOISIER LAURENT·Filed 2011·Granted Nov 27, 2012·2 cites·38 claims
- 0960US2016376269A1Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disordersSABOURAULT NICOLAS LUC·Filed 2016·Application pending·0 cites
- 1059US8759583B2Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidationCEPHALON FRANCE·Filed 2012·Granted Jun 24, 2014·0 cites·31 claims
Join the waitlist — get patent alerts
Get an alert when Nicolas Luc Sabourault files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →